HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells.

AbstractBACKGROUND:
GnRH-II has been shown to exert a strong antiproliferative action on tumors of the female reproductive system. The data so far reported on the effects of GnRH-II on prostate cancer growth are controversial. Moreover, it is still unclear through which receptor [type I or type II GnRH-receptor (GnRH-R)] GnRH-II might modulate cancer cell proliferation.
OBJECTIVE:
The objective of this work was to investigate whether GnRH-II might affect the proliferation of prostate cancer cells and to identify the GnRH-R through which the peptide might exert its activity.
DESIGN:
We investigated the effects of GnRH-II on prostate cancer cell proliferation. We then transfected PC3 cells with a small interfering RNA targeted to type I GnRH-R. After receptor silencing we evaluated the effects of GnRH-II on cell proliferation and on forskolin-induced intracellular cAMP accumulation. Similar experiments were performed by silencing type II GnRH-R.
RESULTS:
GnRH-II exerted an antiproliferative activity on prostate cancer cells. Transfection of PC3 cells with a type I GnRH-R small interfering RNA resulted in a significant decrease of the expression of this receptor. After type I GnRH-R silencing: 1) the antiproliferative effect of GnRH-II was completely abrogated; and 2) GnRH-II lost its capacity to counteract the forskolin-induced cAMP accumulation. On the contrary, type II GnRH-R silencing did not counteract the antiproliferative effect of GnRH-II.
CONCLUSIONS:
GnRH-II exerts a specific and significant antiproliferative action on prostate cancer cells. This antitumor effect is mediated by the activation of type I (but not of type II) GnRH-R and by its coupled cAMP intracellular signaling pathway.
AuthorsMarina Montagnani Marelli, Roberta M Moretti, Stefania Mai, Joanna Januszkiewicz-Caulier, Marcella Motta, Patrizia Limonta
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 94 Issue 5 Pg. 1761-7 (May 2009) ISSN: 1945-7197 [Electronic] United States
PMID19190109 (Publication Type: Journal Article)
Chemical References
  • GNRHR protein, human
  • GNRHR2 protein, human
  • RNA, Small Interfering
  • Receptors, LHRH
  • Cyclic AMP
Topics
  • Blotting, Western
  • Cell Line, Tumor
  • Cell Proliferation
  • Cyclic AMP (physiology)
  • Fluorescent Antibody Technique
  • Gene Silencing
  • Humans
  • Male
  • Prostatic Neoplasms (pathology)
  • RNA, Small Interfering (pharmacology)
  • Receptors, LHRH (genetics, physiology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: